[{"data":1,"prerenderedAt":38},["ShallowReactive",2],{"story-214302-en":3},{"id":4,"slug":5,"slugs":5,"currentSlug":5,"title":6,"subtitle":7,"coverImagesSmall":8,"coverImages":9,"content":10,"questions":11,"relatedArticles":30,"body_color":36,"card_color":37},"214302",null,"Kratom Analog Scheduling Hits Botanical Supplements | Seller Compliance","- DOJ Schedule I listing of MGM-15, MGP1 and MGM-16 puts cat's claw and kratom-adjacent SKUs under heightened US compliance review",[],[],"The news reports that San Francisco health officials linked a fatal overdose in a 37-year-old man to a cat's claw supplement containing MGM-15, a lab-made analog of 7-hydroxymitragynine (7-OH), sold under the Script Botanicals x Maui Labs brand at gas stations. The **U.S. Department of Justice** placed MGM-15, MGP1 and MGM-16 in **Schedule I** in August, and **Utah** officials tied MGP1 and MGM-15 to four deaths statewide. For US-bound sellers of **botanical supplements**, the signal is clear: any SKU whose label does not match its tested contents now carries federal scheduling, product removal and liability exposure.\n\n**Label-to-content mismatch is now the primary enforcement trigger.** The victim's package contained four 100-mg tablets of uncaria tomentosa extract, yet officials said the product was marketed as cat's claw without disclosing MGM-15. The death was ruled an accident caused by toxic effects of kratom alkaloids. On **Amazon Seller Central**, **TikTok Shop** and **Shopify** storefronts, listings that describe a single botanical while containing an undisclosed analog are the highest-risk profile, and platforms are likely to tighten ASIN-level ingredient verification and restricted-keyword screening.\n\nSpecifically for sellers, the operational cost of compliance is front-loaded. Industry practice for a third-party botanical identity and potency test with scheduled-analog screening typically runs about $300-800 per SKU per batch, with turnaround of roughly 5-10 business days. Sellers should maintain certificates of analysis per lot, reconcile them against Supplement Facts panels, and avoid mixing kratom-adjacent extracts in the same warehouse bins as cat's claw inventory. Sellers without this documentation may see listing suppression, Buy Box loss, or account-level review, which can take a high-volume SKU offline for weeks. Industry data suggests compliance gaps in low-price botanical listings are where most delistings concentrate.\n\nLooking at the enforcement trajectory, the DOJ has warned that MGM-16, not yet confirmed in public circulation, could emerge as a substitute, which implies further scheduling actions are plausible within the next 1-3 months. Similar analog-driven scheduling cycles historically have produced a wave of product removals within one to two quarters. Market elimination for non-tested, gas-station-style botanical SKUs could plausibly reach 30-50% of sellers in this niche, while sellers with third-party COAs and clean labels may capture displaced demand. Sellers should monitor DEA Federal Register notices and state warnings from Utah and Washington as leading indicators.",[12,15,18,21,24,27],{"title":13,"answer":14,"author":5,"avatar":5,"time":5},"How can sellers verify their botanical supplements are free of scheduled 7-OH analogs?","Sellers should commission third-party laboratory testing for identity, potency and scheduled-analog screening on each production lot. Industry practice typically costs about $300-800 per SKU per batch with 5-10 business day turnaround. Retain certificates of analysis and reconcile them against the Supplement Facts panel before every listing refresh.",{"title":16,"answer":17,"author":5,"avatar":5,"time":5},"Why does the MGM-15 scheduling matter for cat's claw sellers on Amazon and Shopify?","The DOJ placed MGM-15, MGP1 and MGM-16 in Schedule I in August, meaning any cat's claw or botanical SKU containing these analogs is an unlawful controlled substance regardless of its label. The San Francisco case showed a four-tablet package of 100-mg uncaria tomentosa extract that tested positive for MGM-15 while being marketed as cat's claw. Sellers on Amazon Seller Central or Shopify should expect listing suppression and possible account review if undisclosed analogs are found.",{"title":19,"answer":20,"author":5,"avatar":5,"time":5},"What happens if a botanical listing does not match its tested contents?","The news reports that officials said the product was marketed as cat's claw without disclosing MGM-15, which can trigger regulatory action, product removals and liability claims. Marketplaces may suspend listings or restrict accounts, and a single flagged SKU can take a high-volume ASIN offline for weeks. Correcting labels and documenting testing before a complaint arrives is far less costly than responding to a removal notice.",{"title":22,"answer":23,"author":5,"avatar":5,"time":5},"Is kratom legal to sell on US marketplaces after the DOJ scheduling action?","The news reports that kratom itself is not approved by the FDA for medical use, and the DOJ action targets specific 7-OH-related compounds, MGM-15, MGP1 and MGM-16. Kratom and its alkaloids remain subject to state-level restrictions that vary widely, so sellers should check each target state before listing. Avoid any kratom-adjacent product unless ingredient testing confirms the absence of scheduled analogs.",{"title":25,"answer":26,"author":5,"avatar":5,"time":5},"Will MGM-16 lead to further restrictions on botanical products?","The DOJ has warned that MGM-16, which is not yet confirmed in public circulation, could emerge as a substitute for scheduled analogs. This suggests further scheduling actions are possible within months rather than years. Sellers should monitor DEA Federal Register notices and build screening protocols that cover emerging 7-OH derivatives, not only the three currently listed compounds.",{"title":28,"answer":29,"author":5,"avatar":5,"time":5},"Which states have issued warnings about 7-OH products that sellers should watch?","Utah officials linked MGP1 and MGM-15 to four deaths statewide, and Washington state also issued warnings. Products mislabeled as cat's claw were sold online, in smoke shops and at gas stations. Sellers shipping to these states should treat state health advisories as leading indicators of tighter enforcement and possible additional state-level restrictions.",[31],{"id":32,"title":33,"source":34,"logo":5,"time":35},1658931,"Supplement sold at gas stations blamed for California man’s opioid overdose","https://www.latimes.com/california/story/2026-10-22/supplement-sold-at-gas-stations-blamed-for-california-mans-opioid-overdose","5H AGO","#e37c3aff","#e37c3a4d",1792755053262]